Mon 17 January 2022:
Moderna, a biotech company, is working to develop a single-shot vaccine against flu and coronavirus by autumn 2023, according to its CEO Stephane Bancel, who spoke at the World Economic Forum on Monday.
Last September, Moderna revealed that it was developing a single-component vaccine shot that would protect against both flu and COVID-19.
“The best case scenario will be the fall of 2023,” Bancel said, while commenting on how long it would take to create the single shot vaccine.
According to Bancel, the vaccine is expected to be approved in several nations by that time. The two-component vaccine developed by Moderna has been authorized in the United States and is widely used around the world.
On January 17, CEOs, chiefs of state and government, and other international leaders convened at the Davos Agenda virtual event to discuss the world’s most pressing issues and submit their solutions. Due to the pandemic, the World Economic Forum was hosted virtually for the first time in January 2021.
SOURCE: INDEPENDENT PRESS AND NEWS AGENCIES
FOLLOW INDEPENDENT PRESS:
TWITTER (CLICK HERE)
FACEBOOK (CLICK HERE)
Think your friends would be interested? Share this story!